AzTrials
AzTrials

Fasciitis, PlantarNCT01865734

Comparison of Usual Podiatric Care and Early Physical Therapy for Plantar Heel Pain

A study testing Physical therapy after initial podiatry visit in people with Fasciitis, Plantar, run by Des Moines University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Plantar heel pain (PHP) is one of the most common foot conditions in podiatry and physical therapy practice and often is associated with chronic symptoms, and disability. Persistence of symptoms adds to the economic burden of PHP and cost-effective solutions are needed to reduce this burden. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Fasciitis, Plantar
What is being tested?
Physical therapy after initial podiatry visit
Could I receive a placebo?
No, everyone receives an active treatment
How many people
95 participants
Where
1 siteUnited States
Study dates
Dec 2013to Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Clinical diagnosis of Plantar Heel Pain: Tenderness to palpation of the plantar heel, pain associated with first step after waking, or pain with progression of daily weightbearing
  • Patient's primary complaint is plantar heel pain

Who cannot join

  • Score less than 74/84 on the Foot and Ankle Ability Measure activities of daily living (ADL) subscale
  • Unable to complete questionnaires
  • No treatment for heel pain in last 6 weeks
  • Duration of symptoms greater than 1 year
  • Current fracture of the lower leg, ankle, or foot
  • Neurological condition affecting function of lower leg
Show all 12Show fewer
  • Advanced peripheral artery disease
  • Rheumatoid arthritis
  • Osteoporosis
  • Active cancer
  • Prolonged steroid use
  • Surgery of the lower leg, ankle, or foot

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Des Moines University

    Des Moines, Iowa, 50312

Other trials in United States

About this study

Official title: Comparison of Usual Podiatric Care and Early Physical Therapy for Plantar Heel Pain: A Randomized Clinical Trial

Plantar heel pain (PHP) is one of the most common foot conditions in podiatry and physical therapy practice and often is associated with chronic symptoms, and disability. Persistence of symptoms adds to the economic burden of PHP and cost-effective solutions are needed to reduce this burden. Currently, there is wide variation in treatment, cost, and outcomes of care for PHP. Two practice guidelines are available to direct management patterns, but the guidelines and recent evidence of PHP interventions are unclear about the timing and influence of physical therapy in the multidisciplinary management of PHP. The purpose of this investigation is to compare the outcomes and costs associated with early physical therapy (ePT) following initial presentation to podiatry versus usual podiatric care (uPOD) in individuals with PHP. It is hypothesized that there will be greater improvement and/or reduced costs associated with either ePT or uPOD. In this study, 112 individuals with PHP will be randomized to receive uPOD or ePT after an initial visit with a podiatrist. Treatment provided in the uPOD group will reflect usual management patterns and intervention will be determined by the podiatrist. Treatment provided in the ePT group will be determined by the physical therapist and will focus on impairment-based manual therapy and exercise to the lower half of the body. In addition, evidence-based pain modulating modalities will be integrated into ePT treatment. Comparisons will be made between groups in the Foot and Ankle Ability measure (FAAM), the European Quality of Life (EQ-5D), Numeric Pain Rating Scale (NPRS), Global Rating of Change (GROC), and cost of treatment at 6, 26, and 52, weeks. The association between successful outcome based on GROC score and patient expectation of physical therapy or podiatry, and general expectations of symptom improvement will be analyzed. The results of this investigation will help to determine the impact of ePT to inform practice, update existing guidelines to reduce practice variation, and identify the most cost effective treatment for patients with PHP.

Read the detailed description

This investigation will be a randomized clinical trial comparing participant-reported outcomes and cost-effectiveness of ePT and uPOD with follow up extending to 1 year. Following eligibility screening and completion of study questionnaires participants will be randomized using concealed envelopes and proceed with the intervention of their assigned group. Outcomes will be collected at 6 weeks, 6 months, and 1 year after initial presentation. All outcomes will be completed by the patient without any influence from investigators aware of the group assignment. Data entry and processing will occur by an investigator blinded to group allocation. A small financial incentive will be provided to facilitate completion of outcome measures over the study duration.

Statistical Analysis: Baseline group variables will be summarized using the mean and standard deviation for continuous measures and percentages for categorical measures. Independent t-tests (p<0.05, two-tailed) or the appropriate nonparametric test will be used to compare between group differences in baseline characteristics. Parametric test assumptions will be analyzed for all continuous variables by visual inspection of histograms, use of skewness score within double the standard error of skewness criteria, and Levene's test for homogeneity of the variance. A repeated measures analysis of variance will be used to compare group differences in the FAAM, NPRS, EQ-5D, and number of office visits associated with treatment at each time point. Results will be reported as the group mean, mean difference between groups, 95% confidence intervals, f-value, p-value, power, and effect size. The chi-square test will be used to compare GROC scores between groups at each time point and results will be reported as the chi-square value, p-value, and the frequency per category. The types of treatment based on Current Procedural Terminology (CPT) and Healthcare Common Procedure Coding System (HCPS) codes provided per group will be reported as percentages. Analysis of covariance will be used if any group differences are observed in participant characteristics. Intention to treat analysis will be performed by comparing the complete case analysis to multiple imputation analysis. Multiple imputed data sets will be generated using the Multivariate Imputation by Chained Equations algorithm with SPSS 19.0 for Windows (SPSS Inc., Chicago, IL, USA). Multinomial logistic regression will be used to obtain pooled regression estimates from the data sets which will be used for analysis. Post-randomization exclusion of included participants that did not meet eligibility criteria or that did not receive intervention will be considered for exclusion of the analysis by an independent, blinded adjudication committee that will evaluate all randomized participants. Any cross-overs will be analyzed in the original group they were assigned to and compared to an analysis that excludes cross-overs.

Participant expectations and preferences for ePT or uPOD will be categorized into 3 categories; matched, unmatched and neutral. Participants will be labelled 'matched' if they are allocated to a group for which they have expressed a higher expectation of benefit. A higher expectation will be denoted by comparison of visual analog ratings between the groups (ePT and uPOD). Unmatched participants will be those who are allocated to the treatment group for which they have a lower expectation of benefit. Neutral participants will be those who indicate the same level of expectation for both treatments. Similar categorizations will be made for participant preference based upon their response to the treatment preference question. General expectations of improvement will be dichotomized into met or unmet based upon rankings at the 6 week, 6 month, and 1 year follow-up relative to baseline rankings. Participants that demonstrate 6 week, 6 month, and 1 year ranks equal to or higher than baseline will be considered to have met their global expectations of improvement. Participants that demonstrate rankings below baseline expectations will be considered to have unmet global expectations of improvement. A chi-square test of independence will be used to compare the proportions of individuals with matched/unmatched/neutral expectations or preferences to global expectations (met or unmet). In addition, differences in expectation and preference categories will be analyzed relative to treatment success using a chi-square test of independence. Treatment success will be determined by the GROC at each time period with success defined as a GROC of +5, "a great deal better," or greater.

Power Analysis: Sample size estimates were calculated based on the primary outcome measure, the FAAM, at 6 months. In the absence of research comparing physical therapy and podiatry interventions or podiatry interventions using the FAAM as an outcome measure, sample size calculations were based on achieving a clinically meaningful difference between the groups and details from a recent clinical trial by Cleland et al that used similar methods to this investigation. Sample size estimate was made using G*Power 3.1.5 based on detecting a difference between groups greater than the minimal clinically important difference (MCID; ie, 9 point change) of the FAAM at 6 months with an alpha level of 0.05, 80% power, and pooled sample variance of 14.5 from Cleland et al This resulted in an effect size of 0.62 and 42 participants needed per group. This estimate is similar to the effect size of 0.69 achieved in the Cleland et al study that had 27 subjects per 2 treatment groups. To account for participants who drop-in or drop-out of treatment, in addition to the possibility of some participants not returning the FAAM questionnaire, the sample will be increased by 33% resulting in 56 participants per group. This estimate is conservative relative to the 3% drop-out rate and 7% rate of individuals that did not return outcome forms at the 6 month follow-up in the Cleland et al investigation. Significant effort will be made to retain subjects to include financial incentives and follow-up by the research assistant to assure completion and return of all outcome forms. The focus, and consequently the power analysis, of this investigation is on functional outcome (based on FAAM scores) and therefore may result in underpowered analysis of secondary variables.

Being tested
Physical therapy after initial podiatry visit, Usual care provided by podiatry
Keywords
Fasciitis, Plantar, Heel Pain, Physical Therapy, Podiatry, Musculoskeletal Manipulations, Exercise Therapy
Medical subject headings
Fasciitis, Plantar

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical therapy after initial podiatry visitOther

    Individuals in the early physical therapy group will receive physical therapy in accordance with the American Physical Therapy Association plantar heel pain practice guidelines and recent evidence in support of manual therapy intervention. Treatment provided will be based on identified impairments and may include manual therapy (joint and soft tissue mobilization/thrust manipulation to the lower half of the body), lower leg and plantar foot specific stretching/self mobilization, foot and lower leg muscle performance training, night splints, taping, over the counter orthotics/heel cup/heel cushion, and iontophoresis. Specific intervention will be selected at the discretion of the treating physical therapist.

  • Usual care provided by podiatryOther

    Individuals in the usual podiatric care group will receive care typical of podiatry management of plantar heel pain. According to practice guidelines, the first 6 weeks of treatment includes foot taping/padding, home stretching exercises, arch support/heel cup, shoe recommendations, oral anti-inflammatories, and corticosteroid injection. The next 6 months may include corticosteroid injection, custom orthotics, night splint, immobilization, and physical therapy. If unresponsive after 6 months of treatment, extracorporal shock wave therapy or a fasciotomy surgery is considered. Additionally, the podiatrist may order radiographs or ultrasound imaging within their scope of practice. Specific intervention will be selected at the discretion of the treating podiatrist.

Study groups in NCT01865734
Study groupRoleWhat they receive
Early Physical TherapyExperimentalPhysical therapy after initial podiatry visit
Receives: Other: Physical therapy after initial podiatry visit
Usual Podiatric CareActive comparatorUsual care provided by podiatry
Receives: Other: Usual care provided by podiatry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Foot and Ankle Ability Measure

    Measured: 6 months

Secondary outcomes (4)
  1. Numeric Pain Rating Scale

    The average of the least, current, and worst pain in the last week will be used.

    Measured: Baseline, 6 weeks, 6 months, 1 year

  2. Global Rating of Change Scale

    Measured: 6 weeks, 6 months, 1 year

  3. Incremental cost-effectiveness ratio

    Incremental cost-effectiveness ratio will be calculated per quality-adjusted life year (QALY) gained determined by response on the European Quality of Life - 5 Dimensions

    Measured: 6 weeks, 6 months, 1 year

  4. Foot and Ankle Ability Measure

    Measured: Baseline, 6 weeks, and 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 May 2013 (estimated)
  2. Study startDec 2013
  3. Primary completionNov 2017
  4. Study completionNov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
95 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01865734
Sponsor's protocol ID
04-13-02
Status last verified
Jan 2019
First submitted
24 May 2013
Last updated
22 Jan 2019
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Undecided

Publications

  • McClinton SM, Heiderscheit BC, Flynn TW, Pinto D. Cost-Effectiveness of Physical Therapist Treatment in Addition to Usual Podiatry Management of Plantar Heel Pain: Economic Evaluation of a Randomized Clinical Trial. Phys Ther. 2025 Nov 3;105(11):pzaf119. doi: 10.1093/ptj/pzaf119.

    PubMed 41042252
  • McClinton SM, Heiderscheit BC, McPoil TG, Flynn TW. Effectiveness of physical therapy treatment in addition to usual podiatry management of plantar heel pain: a randomized clinical trial. BMC Musculoskelet Disord. 2019 Dec 28;20(1):630. doi: 10.1186/s12891-019-3009-y.

    PubMed 31883516
  • McClinton SM, Flynn TW, Heiderscheit BC, McPoil TG, Pinto D, Duffy PA, Bennett JD. Comparison of usual podiatric care and early physical therapy intervention for plantar heel pain: study protocol for a parallel-group randomized clinical trial. Trials. 2013 Dec 3;14:414. doi: 10.1186/1745-6215-14-414.

    PubMed 24299257

Questions about this trial

What is this clinical trial studying?

A study testing Physical therapy after initial podiatry visit in people with Fasciitis, Plantar, run by Des Moines University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Foot and Ankle Ability Measure (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01865734, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in